Cargando…

Overcoming Gleevec-resistance by blocking oncogene addiction in malignant hematologic cells

Detalles Bibliográficos
Autor principal:	Pan, Jingxuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Meeting Abstract
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3337264/ http://dx.doi.org/10.1186/1756-8722-5-S1-A6

Ejemplares similares

Nonlymphoma hematological malignancies in systemic lupus erythematosus
por: Lu, M, et al.
Publicado: (2012)

Effects of STI571 (gleevec) on pancreatic cancer cell growth
por: Li, Junsheng, et al.
Publicado: (2003)

T-cell immunodeficiency and reconstruction based on TCR rearrangement analysis in hematological malignancy: update from 2011 ASH annual meeting
por: Li, Yangqiu
Publicado: (2012)

A CINful way to overcome addiction: how chromosomal instability enables cancer to overcome its oncogene addiction
por: Bronder, Daniel, et al.
Publicado: (2020)

Addiction and guilt
por: Paraskevopoulos, Nikolaos
Publicado: (2010)

Energetic dissection of Gleevec’s selectivity towards human tyrosine kinases
por: Agafonov, R.V., et al.
Publicado: (2014)

Molecular Testing in Hematologic Malignancies
por: Zitella, Laura J.
Publicado: (2022)

The primary prevention in the service of addiction
por: Koutras, Vasilios
Publicado: (2010)

The family's attitude towards addiction
por: Kalampalikis, Vasileios
Publicado: (2010)

The nature of addiction and drug rehabilitation
por: Kaloterakis, Phaedon
Publicado: (2010)

Antifungal Resistance and Predictors of Response in Patients with Hematologic Malignancy
por: Wey, Shiuan (Shannon), et al.
Publicado: (2017)

Resistance Mechanisms to CAR T-Cell Therapy and Overcoming Strategy in B-Cell Hematologic Malignancies
por: Song, Moo-Kon, et al.
Publicado: (2019)

Targeting oncogenes in advanced melanoma
por: McArthur, GA
Publicado: (2012)

Therapeutic options for chronic myeloid leukemia: focus on imatinib (Glivec(®), Gleevec™)
por: Henkes, Martin, et al.
Publicado: (2008)

Pityriasis rosea-like Drug Eruption Induced by Imatinib Mesylate (Gleevec™)
por: Cho, Ah Young, et al.
Publicado: (2011)

Subcapsular Liver Hematoma in Metastatic GIST Complicating Imatinib (Gleevec) Therapy
por: Shankar, Sridhar
Publicado: (2015)

Editorial: The mechanism and novel strategies of overcoming resistance of hematological malignancies to CAR-T cell killing
por: Zhang, Tingting, et al.
Publicado: (2022)

Treatment of tobacco addiction using the Feeling-State Addiction Protocol (FSAP) of the Eye Movement Desensitization and Reprocessing (EMDR) treatment
por: Tsoutsa, Aikaterini, et al.
Publicado: (2014)

A phase II study of epigenetic therapy with hydralazine and magnesium valproate to overcome chemotherapy resistance in refractory solid tumors
por: Candelaria, Myrna, et al.
Publicado: (2007)

Alternative approaches of addiction and dominant scientific perspectives
por: Lainas, Sotiris
Publicado: (2010)

Does heroin addiction makes temperamental changes?
por: Martinova, Hristina, et al.
Publicado: (2010)

Gleevec, an Abl Family Inhibitor, Produces a Profound Change in Cell Shape and Migration
por: Chen, Zaozao, et al.
Publicado: (2013)

Revisiting NTRKs as an emerging oncogene in hematological malignancies
por: Joshi, Sunil K., et al.
Publicado: (2019)

2019–2020 Drug Updates in Hematologic Malignancies
por: Finnes, Heidi D.
Publicado: (2021)

2018–2019 Drug Updates in Hematologic Malignancies
por: Held, Lauren
Publicado: (2020)

2020–2021 Drug Updates in Hematologic Malignancies
por: Hanna, Kirollos
Publicado: (2022)

2021–2022 Drug Updates in Hematologic Malignancies
por: Tobin, Jenni
Publicado: (2023)

Combination strategies to overcome resistance to the BCL2 inhibitor venetoclax in hematologic malignancies
por: Yue, XiaoYan, et al.
Publicado: (2020)

Overcoming apoptosis resistance in high risk acute lymphoblastic leukemia by SMAC mimetics in a preclinical ALL xenograft model in vivo
por: Schirmer, Melanie, et al.
Publicado: (2014)

Truth and lies about the social rehabilitation of drug addiction
por: Georgakas, Panagiotis
Publicado: (2010)

Organizational capacity to eliminate outcome disparities in addiction health services
por: Guerrero, Erick G, et al.
Publicado: (2015)

Integrating addiction medicine training into medical school and residency curricula
por: Klimas, Jan, et al.
Publicado: (2015)

Imatinib mesylate (Gleevec) downregulates telomerase activity and inhibits proliferation in telomerase-expressing cell lines
por: Uziel, O, et al.
Publicado: (2005)

Implementation of brief intervention for alcohol by Brazilian health professionals: overcoming difficulties
por: Zerbetto, Sonia Regina, et al.
Publicado: (2013)

Overcoming barriers to implementing brief intervention: a knowledge transfer partnership
por: Jordan, Paul, et al.
Publicado: (2013)

Cloned HTLV-1+CD4+, but not CD8+, T-cells display an oncogenic miRNome
por: Vernin, Céline, et al.
Publicado: (2011)

Targeting SAMHD1: To overcome multiple anti-cancer drugs resistance in hematological malignancies
por: Wang, Tao, et al.
Publicado: (2022)

Drug addictions and sexual violence in childhood and adolescence: analyzing life stories
por: Leão Doescher, Andréa Marques, et al.
Publicado: (2013)

Management of hematological patients in ICU: a retrospective study of 110 patients
por: Larché, J, et al.
Publicado: (2001)

Integrated genomic analysis and functional characterisation of novel oncogenes in ovarian cancer
por: Davis, SJ, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_pvblrrd6m88og7kn4u01clq8o1